End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions

E Ritz, I Rychlík, F Locatelli, S Halimi - American journal of kidney diseases, 1999 - Elsevier
The incidence of patients with end-stage renal failure and diabetes mellitus type 2 as a
comorbid condition has increased progressively in the past decades, first in the United States …

Oxidative stress in end‐stage renal disease: an emerging threat to patient outcome

F Locatelli, B Canaud, KU Eckardt… - Nephrology Dialysis …, 2003 - academic.oup.com
… Francesco Locatelli, as chairman of the Accord programme, wrote the Introduction and
oversaw the consistency of the manuscript edition of the Accord workshop. Other sections were …

[HTML][HTML] The burden of kidney disease: improving global outcomes

…, R Barsoum, KU Eckardt, A Levin, N Levin, F Locatelli… - Kidney international, 2004 - Elsevier
The burden of kidney disease: Improving global outcomes. Chronic kidney disease (CKD) is
a worldwide public health problem. There is an increasing incidence and prevalence of …

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

K Le Blanc, F Frassoni, L Ball, F Locatelli, H Roelofs… - The Lancet, 2008 - thelancet.com
Background Severe graft-versus-host disease (GVHD) is a life-threatening complication after
allogeneic transplantation with haemopoietic stem cells. Mesenchymal stem cells modulate …

[HTML][HTML] Effect of the angiotensin-converting–enzyme inhibitor benazepril on the progression of chronic renal insufficiency

G Maschio, D Alberti, G Janin, F Locatelli… - … England Journal of …, 1996 - Mass Medical Soc
Background Drugs that inhibit angiotensin-converting enzyme slow the progression of renal
insufficiency in patients with diabetic nephropathy. Whether these drugs have a similar …

[HTML][HTML] Normalization of hemoglobin level in patients with chronic kidney disease and anemia

TB Drüeke, F Locatelli, N Clyne… - … England Journal of …, 2006 - Mass Medical Soc
Background Whether correction of anemia in patients with stage 3 or 4 chronic kidney disease
improves cardiovascular outcomes is not established. Methods We randomly assigned …

GD2-CART01 for relapsed or refractory high-risk neuroblastoma

…, V Folsi, C Quintarelli, F Locatelli - … England Journal of …, 2023 - Mass Medical Soc
Background Immunotherapy with chimeric antigen receptor (CAR)–expressing T cells that
target the disialoganglioside GD2 expressed on tumor cells may be a therapeutic option for …

Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study

…, M Zompatori, C Filippini, F Locatelli… - The lancet Respiratory …, 2020 - thelancet.com
Background Patients with COVID-19 can develop acute respiratory distress syndrome (ARDS),
which is associated with high mortality. The aim of this study was to examine the …

[HTML][HTML] Outcome of cord-blood transplantation from related and unrelated donors

…, A Boyer-Chammard, F Locatelli… - … England Journal of …, 1997 - Mass Medical Soc
Background Cord-blood banks have increased the use of cord-blood transplantation in
patients with hematologic disorders. We have established a registry containing information on …

[HTML][HTML] Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS)

…, KP McCullough, DA Goodkin, F Locatelli… - Kidney international, 2003 - Elsevier
… Goodkin , Francesco Locatelli , Shunichi Fukuhara , Eric W. Young , Kiyoshi Kurokawa ,
Akira Saito , Jürgen Bommer , Robert A. Wolfe , … F. Valderrabano, R. Jofre, JM Lopez-Gomez …